Table 1.
Dose-escalation or de-escalation rule for the Bayesian optimal interval design.
| Actions | The number of patients treated at the current dose | ||||||||||||||
|
|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| Escalate if the number of DLTa is ≤ | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| De-escalate if the number of DLT is ≥ | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 6 | 6 |
| Eliminate if the number of DLT is ≥ | N/Ab | N/A | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 |
aDLT: dose-limiting toxicity.
bN/A: not applicable.